BP p.l.c.

Transaction in Own Shares

BP p.l.c. (the "Company") announces that on 11 January 2022 it has purchased, in accordance with the authority granted by shareholders at the 2021 Annual General Meeting of the Company, a total of 5,448,617 of its ordinary shares of $0.25 each ("Shares") on the London Stock Exchange and Cboe (UK) as part of the buyback programme announced on 10 January 2022 (the "Programme") and as detailed below:

  London Stock Exchange Cboe (UK)/BXE Cboe (UK)/CXE Number of Shares purchased: 3,858,283 800,000 790,334 Highest price paid per Share (pence): 370.0000 370.0000 370.0000 Lowest price paid per Share (pence): 361.6500 361.7500 361.9500 Volume weighted average price paid per Share (pence): 366.4791 366.4344 366.4881  

The Company intends to cancel these shares in accordance with the intentions expressed in connection with the authority granted by its shareholders at the Company's 2021 Annual General Meeting.

The schedule below contains detailed information about the purchases made by Citigroup Global Markets Limited (intermediary code: SBILGB2L) on the date of purchase as part of the Programme.

Further enquiries:

bp Investor Relations +44(0) 207 496 4000

Schedule of Purchases

Shares purchased: BP p.l.c. (ISIN CODE: GB0007980591)

Aggregate information:

Venue Volume-weighted
average price (pence) Aggregated volume London Stock Exchange 366.4791 3,858,283 Cboe (UK) - BXE 366.4344 800,000 Cboe (UK) - CXE 366.4881 790,334  

Individual transactions:

To view details of the individual transactions, please paste the following URL into the address bar of your browser.

http://www.rns-pdf.londonstockexchange.com/rns/1273Y_1-2022-1-11.pdf
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.